Craig Mayer, Nick WIlliams, Vojtech Huser
Lister Hill National Center for Biomedical Communications, National Library of Medicine, NIH, Bethesda, MD

See the full regCTG repository at https://github.com/lhncbc/CRI/tree/master/regCTG

To return to the list of conditions and view other reports go to https://lhncbc.github.io/CRI/regCTG/regCTG-condition_report_links.html

Study Counts

Type Study_count
Total_Studies 114
interventional 57
Observational 49
Registry 8

Studies over Time by Start Date

```

Interventional Trials

Intervention Type

intervention_type Study_Count
Drug|placebo 14
Drug 12
Device 10
Procedure 9
Other 4
Behavioral 3
Diagnostic Test 2
Behavioral|Drug 1
Drug|Other|placebo 1
Drug|Procedure 1

Count of Studies by Intervention (normalized and mapped)

Interventions over Time

Yearly studies for each intervention by start date

Studies by Country

Country Study_Count
United States 23
Denmark 4
France 4
Russian Federation 3
United Kingdom 3
United States|Canada 3
Canada 2
Poland 2
Spain 2
United States|Belgium|Czechia|Denmark|France|Germany|Israel|Italy|Netherlands|Poland|Portugal|Spain|United Kingdom 2
Brazil 1
China 1
Czechia 1
Germany 1
Germany|Italy|Serbia|United Kingdom 1
Italy 1
United States|Germany|Korea, Republic of|Spain 1
United States|Korea, Republic of|Poland 1
United States|Spain 1

Sites per Study

Site_count Study_Count
1 40
2 2
3 2
4 1
5 1
6 1
7 3
11 1
15 1
32 1
47 1
52 1
64 1
72 1

Phase

Phase Study_Count
N/A 23
Phase 2 20
Phase 1 5
Phase 3 4
Phase 4 3
Phase 2/Phase 3 2

Number of Arms

Number_of_Arms Count_of_Studies
1 13
2 28
3 5
4 1
6 1
8 1
NA 8

Enrollment Metrics by Phase

Measure N.A Phase.1 Phase.2 Phase.2.Phase.3 Phase.3 Phase.4
Min. 10.0000 15 12.0 39.00 20.00 14.00000
1st Qu. 25.5000 24 30.5 106.75 21.50 22.50000
Median 72.0000 42 47.0 174.50 56.00 31.00000
Mean 100.6087 59 74.0 174.50 95.75 31.66667
3rd Qu. 128.0000 100 72.5 242.25 130.25 40.50000
Max. 500.0000 114 249.0 310.00 251.00 50.00000

Trial Group Type

group_type Group_Count
Experimental 46
Active Comparator 20
Placebo Comparator 18
Other 10
NA 8
No Intervention 6
Sham Comparator 2

Intervention Model

intervention_model Study_Count
Parallel Assignment 28
Single Group Assignment 13
Crossover Assignment 7
NA 7
Sequential Assignment 2

Primary Purpose

primary_purpose Study_Count
Treatment 42
Diagnostic 5
Basic Science 4
Health Services Research 2
Supportive Care 2
Other 1
Screening 1

Observational Studies

Studies by Country

Country Study_Count
United States 26
China 5
France 4
Germany 3
NA 2
Singapore 2
United States|Canada 2
Belgium 1
Canada 1
Greece 1
Netherlands 1
Poland 1

Sites per Study

Site_count Study_Count
1 43
2 1
3 1
5 1
9 1
12 1
13 1

Enrollment Metrics

Measure Observational
Min 20.0000
1st Qu 110.0000
Median 200.0000
Mean 857.1915
3rd Qu 572.0000
Max 9999.0000

Observation Model

observational_model Study_Count
Cohort 26
NA 14
Case-Control 5
Case-Only 2
Family-Based 2

Time Perspective

time_perspective Study_Count
Prospective 30
NA 12
Retrospective 4
Cross-Sectional 2
Other 1

Registries

Studies by Country

Country Study_Count
United States 2
Canada 1
Italy 1
Korea, Republic of 1
Sweden 1
United States|Australia|Canada|New Zealand|United Kingdom 1
United States|Canada|Germany|Italy|Netherlands|United Kingdom 1

Sites per Study

Site_count Study_Count
1 6
36 1
44 1

Enrollment Metrics

Measure Registries
Min 99.00
1st Qu 250.00
Median 1575.00
Mean 2618.50
3rd Qu 3324.75
Max 10000.00

Registry Model

observational_model Study_Count
Case-Only 3
Cohort 3
Family-Based 2

Time Perspective

time_perspective Study_Count
Prospective 8

Follow-up

target_duration Study_Count
5 Years 3
2 Years 2
1 Day 1
10 Years 1
3 Years 1

Overview of Studies

Interventional Trials

#If less then 500 trials

nct_id brief_title link overall_status source primary_completion_date
NCT04418297 A Phase I Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of CT-G20 in Subjects With Obstructive Hypertrophic Cardiomyopathy https://ClinicalTrials.gov/show/NCT04418297 Recruiting Celltrion 2020-12-31
NCT03335332 High Intensity Exercise for Increasing Fitness in Patients With Hypertrophic Cardiomyopathy https://ClinicalTrials.gov/show/NCT03335332 Recruiting University of Texas Southwestern Medical Center 2020-06-30
NCT03249272 Microvascular Dysfunction in Nonischemic Cardiomyopathy: Insights From CMR Assessment of Coronary Flow Reserve https://ClinicalTrials.gov/show/NCT03249272 Completed Duke University 2019-03-31
NCT03225001 The PARTNER II Trial: Placement of AoRTic TraNscathetER Valves II - PARTNER II - Nested Registry 3/Valve-in-Valve https://ClinicalTrials.gov/show/NCT03225001 Active, not recruiting Edwards Lifesciences 2016-12-16
NCT03178357 “Cardiac Rehabilitation in Patients With Hypertrophic Cardiomyopathy”. https://ClinicalTrials.gov/show/NCT03178357 Recruiting Institute of Cardiology, Warsaw, Poland 2020-12-31
NCT02842242 A Phase 2 Open-label Pilot Study Evaluating MYK-461 in Subjects With Symptomatic Hypertrophic Cardiomyopathy and Left Ventricular Outflow Tract Obstruction https://ClinicalTrials.gov/show/NCT02842242 Completed MyoKardia, Inc. 2017-11-30
NCT02619825 Non-Invasive Evaluation of Myocardial Stiffness by Elastography in Pediatric Cardiology (Elasto-Pédiatrie) https://ClinicalTrials.gov/show/NCT02619825 Completed French Cardiology Society 2017-05-31
NCT02590809 Hypertrophic Cardiomyopathy Symptom Release by BX1514M https://ClinicalTrials.gov/show/NCT02590809 Completed University Hospital, Bordeaux 2016-07-06
NCT02329184 Study Evaluating the Safety, Tolerability and Preliminary Pharmacokinetics and Pharmacodynamics of MYK-461 https://ClinicalTrials.gov/show/NCT02329184 Completed MyoKardia, Inc. 2016-03-31
NCT02054221 Surgical Treatment of Hypertrophic Obstructive Cardiomyopathy With Severe Mitral Insufficiency. https://ClinicalTrials.gov/show/NCT02054221 Completed Meshalkin Research Institute of Pathology of Circulation 2015-05-31
NCT01729702 Neurohormonal Parameters in Hypertrophic Cardiomyopathies https://ClinicalTrials.gov/show/NCT01729702 Completed French Cardiology Society 2013-12-31
NCT01721967 Ranolazine for the Treatment of Chest Pain in HCM Patients https://ClinicalTrials.gov/show/NCT01721967 Completed Duke University 2015-11-30
NCT01631006 Effects of Continous Positive Airway Pressure (CPAP) in Hypertrophic Cardiomyopathy https://ClinicalTrials.gov/show/NCT01631006 Completed University of Sao Paulo 2012-12-31
NCT01537926 Hypertrophic Regression With N-Acetylcysteine in HCM https://ClinicalTrials.gov/show/NCT01537926 Completed The University of Texas Health Science Center, Houston 2016-12-31
NCT01447654 Inhibition of the Renin Angiotensin System With Losartan in Patients With Hypertrophic Cardiomyopathy https://ClinicalTrials.gov/show/NCT01447654 Completed Rigshospitalet, Denmark 2014-06-30
NCT01332162 CArdiac Desynchronization In Obstructive HCM, CARDIO-HCM https://ClinicalTrials.gov/show/NCT01332162 Recruiting Hospital Clinic of Barcelona 2019-12-31
NCT04355260 The Clinical Research of the Safety and Effectiveness Evaluation for Using Echocardiography-guided Liwen RF Radiofrequency Ablation System to Treat Hypertrophic Obstructive Cardiomyopathy https://ClinicalTrials.gov/show/NCT04355260 Recruiting Xijing Hospital 2020-06-30
NCT04222101 Association of Insulin Resistance and FGF21 on Cardiac Function in Pediatric Dilated Cardiomyopathy https://ClinicalTrials.gov/show/NCT04222101 Recruiting Le Bonheur Children’s Hospital 2021-01-01
NCT04164732 Study of Efficacy of Oral Sacubitril/Valsartan in Adult Patients With Non-obstructive Hypertrophic Cardiomyopathy https://ClinicalTrials.gov/show/NCT04164732 Recruiting Novartis 2022-02-22
NCT04157205 Prospective Evaluation Of Exercise-Induced Cardiac Conduction Instability In Predicting Ventricular Fibrillation Events In Hypertrophic Cardiomyopathy https://ClinicalTrials.gov/show/NCT04157205 Recruiting Imperial College London 2024-11-01
NCT04141891 Advancing Understanding of Transportation Options https://ClinicalTrials.gov/show/NCT04141891 Recruiting University of Colorado, Denver 2023-08-01
NCT04133532 Effect of Metoprolol in Post Alcohol Septal Ablation Patients With Hypertrophic Cardiomyopathy https://ClinicalTrials.gov/show/NCT04133532 Recruiting University Hospital, Motol 2021-11-01
NCT04066777 The Effect of TASH in Patients With HOCM https://ClinicalTrials.gov/show/NCT04066777 Recruiting Aarhus University Hospital Skejby 2022-01-01
NCT03953989 Effects of Ranolazine on Coronary Microvascular Dysfunction in Patients With Hypertrophic Cardiomyopathy https://ClinicalTrials.gov/show/NCT03953989 Recruiting IRCCS San Raffaele 2019-07-31
NCT03906734 Mitral Valve Management During Septal Myectomy https://ClinicalTrials.gov/show/NCT03906734 Completed Meshalkin Research Institute of Pathology of Circulation 2016-10-28
NCT03877731 Mitral Valve in Hypertrophic Cardiomyopathy https://ClinicalTrials.gov/show/NCT03877731 Completed Tomsk National Research Medical Center of the Russian Academy of Sciences 2019-05-30
NCT03832660 Sacubitril/Valsartan vs Lifestyle in Hypertrophic Cardiomyopathy https://ClinicalTrials.gov/show/NCT03832660 Recruiting Newcastle University 2021-11-30
NCT03767855 A Single and Multiple Ascending Dose Study of CK-3773274 in Healthy Adult Subjects https://ClinicalTrials.gov/show/NCT03767855 Completed Cytokinetics 2020-01-03
NCT03723655 A Long-Term Safety Extension Study of Mavacamten in Adults Who Have Completed MAVERICK-HCM or EXPLORER-HCM https://ClinicalTrials.gov/show/NCT03723655 Enrolling by invitation MyoKardia, Inc. 2022-06-30
NCT03550573 3D Non-invasive Myocardial Electrical Propagation Mapping as a New Tool to Predict Sudden Death Risk in Patients With Hypertrophic Cardiomyopathy https://ClinicalTrials.gov/show/NCT03550573 Recruiting Hospices Civils de Lyon 2020-08-31
NCT03537183 Will Elevated Left Ventricle Filling Pressures Decrease by a Group Exercise Program in Patients With Hypertrophic CardioMyopathy? https://ClinicalTrials.gov/show/NCT03537183 Recruiting Bispebjerg Hospital 2021-09-01
NCT03532802 The Effect of Metoprolol in Patients With Hypertrophic Obstructive Cardiomyopathy. https://ClinicalTrials.gov/show/NCT03532802 Recruiting Aarhus University Hospital Skejby 2019-12-01
NCT03496168 Extension Study of Mavacamten (MYK-461) in Adults With Symptomatic Obstructive Hypertrophic Cardiomyopathy Previously Enrolled in PIONEER https://ClinicalTrials.gov/show/NCT03496168 Active, not recruiting MyoKardia, Inc. 2022-01-31
NCT03470545 Clinical Study to Evaluate Mavacamten (MYK-461) in Adults With Symptomatic Obstructive Hypertrophic Cardiomyopathy https://ClinicalTrials.gov/show/NCT03470545 Completed MyoKardia, Inc. 2020-03-14
NCT03450252 Pacemaker Therapy for Drug-refractory Symptoms in Mid-cavity Hypertrophic Cardiomyopathy https://ClinicalTrials.gov/show/NCT03450252 Recruiting Barts & The London NHS Trust 2021-02-28
NCT03442764 A Phase 2 Study of Mavacamten in Adults With Symptomatic Non-Obstructive Hypertrophic Cardiomyopathy (nHCM) https://ClinicalTrials.gov/show/NCT03442764 Completed MyoKardia, Inc. 2020-01-07
NCT01150461 Effect of Losartan in Patients With Nonobstructive Hypertrophic Cardiomyopathy https://ClinicalTrials.gov/show/NCT01150461 Completed Massachusetts General Hospital 2010-07-31
NCT01127061 Study of Exercise Training in Hypertrophic Cardiomyopathy https://ClinicalTrials.gov/show/NCT01127061 Completed University of Michigan 2015-09-30
NCT01081093 Biventricular Pacing in Hypertrophic Cardiomyopathy After Aortic Valve Replacement https://ClinicalTrials.gov/show/NCT01081093 Completed Johann Wolfgang Goethe University Hospital 2014-08-31
NCT00821353 Antiarrhythmic Therapy Versus Catheter Ablation for Atrial Fibrillation in Hypertrophic Cardiomyopathy https://ClinicalTrials.gov/show/NCT00821353 Completed Institute of Cardiology, Warsaw, Poland 2012-06-30
NCT01614717 Triple Chamber Pacing in Hypertrophic Obstructive Cardiomyopathy (HOCM) Patients - TRICHAMPION STUDY https://ClinicalTrials.gov/show/NCT01614717 Active, not recruiting Abbott Medical Devices 2020-09-30
NCT03003299 The PARTNER 3 - AVIV Trial https://ClinicalTrials.gov/show/NCT03003299 Recruiting Edwards Lifesciences 2021-12-31
NCT02674958 Mobilization of Endothelial Progenitor Cells and Aspirin https://ClinicalTrials.gov/show/NCT02674958 Recruiting Ottawa Heart Institute Research Corporation 2022-12-31
NCT04219826 REDWOOD-HCM: Randomized Evaluation of Dosing With CK-3773274 in Obstructive Outflow Disease in HCM https://ClinicalTrials.gov/show/NCT04219826 Recruiting Cytokinetics 2021-04-30
NCT02560467 Perfusion Imaging With Myocardial Contrast Echocardiography in HCM https://ClinicalTrials.gov/show/NCT02560467 Active, not recruiting Oregon Health and Science University 2019-09-01
NCT01912534 Valsartan for Attenuating Disease Evolution In Early Sarcomeric HCM https://ClinicalTrials.gov/show/NCT01912534 Active, not recruiting HealthCore-NERI 2019-07-31
NCT01736566 A Pilot Project Exploring the Impact of Whole Genome Sequencing in Healthcare https://ClinicalTrials.gov/show/NCT01736566 Active, not recruiting Brigham and Women’s Hospital 2016-11-04
NCT00500552 Perhexiline Therapy in Patients With Hypertrophic Cardiomyopathy https://ClinicalTrials.gov/show/NCT00500552 Completed University Hospital Birmingham 2010-08-31
NCT00319982 Treatment of Preclinical Hypertrophic Cardiomyopathy With Diltiazem https://ClinicalTrials.gov/show/NCT00319982 Completed Brigham and Women’s Hospital 2012-12-31
NCT00317967 Study to Determine if Atorvastatin Reduces Size and Stiffness of Muscle in the Left Ventricle of the Heart https://ClinicalTrials.gov/show/NCT00317967 Completed University of Calgary 2010-10-31
NCT00001965 Cyclosporine A to Treat Hypertrophic Cardiomyopathy (HCM) https://ClinicalTrials.gov/show/NCT00001965 Completed National Institutes of Health Clinical Center (CC) NA
NCT00035386 Alcohol Septal Ablation in Obstructive Hypertrophic Cardiomyopathy: A Pilot Study https://ClinicalTrials.gov/show/NCT00035386 Completed National Institutes of Health Clinical Center (CC) NA
NCT00011076 Pirfenidone to Treat Hypertrophic Cardiomyopathy https://ClinicalTrials.gov/show/NCT00011076 Completed National Institutes of Health Clinical Center (CC) NA
NCT00001960 Studying the Effectiveness of Pacemaker Therapy in Children Who Have Thickened Heart Muscle https://ClinicalTrials.gov/show/NCT00001960 Completed National Institutes of Health Clinical Center (CC) NA
NCT00001894 A Comparison of Two Treatments: Pacemaker and Percutaneous Transluminal Septal Ablation for Hypertrophic Cardiomyopathy https://ClinicalTrials.gov/show/NCT00001894 Completed National Institutes of Health Clinical Center (CC) NA
NCT00001631 Study of Blood Flow in Heart Muscle https://ClinicalTrials.gov/show/NCT00001631 Completed National Institutes of Health Clinical Center (CC) NA
NCT00001396 Natural History and Results of Dual Chamber (DDD) Pacemaker Therapy of Children With Obstructive Hypertrophic Cardiomyop… https://ClinicalTrials.gov/show/NCT00001396 Completed National Institutes of Health Clinical Center (CC) NA

Observational Studiess

#If less then 500 studies

nct_id brief_title link overall_status source primary_completion_date
NCT04112511 Study of Myocardial Deformation Parameters in Patients With Hypertrophic Cardiomyopathy https://ClinicalTrials.gov/show/NCT04112511 Active, not recruiting AHEPA University Hospital 2020-12-31
NCT03362164 Evaluation of HEArt invoLvement in Patients With FABRY Disease https://ClinicalTrials.gov/show/NCT03362164 Recruiting Wuerzburg University Hospital 2032-03-31
NCT03327623 Sleep Apnea and Hypertrophic Cardiomyopathy (HCM) https://ClinicalTrials.gov/show/NCT03327623 Recruiting Mayo Clinic 2021-06-30
NCT03271385 Differentiating Hypertrophic Cardiomyopathy From Hypertensive Heart Disease https://ClinicalTrials.gov/show/NCT03271385 Recruiting RenJi Hospital 2020-06-30
NCT03092843 Functional Capacity and Quality of Life Following Septal Myectomy in Patients With HCM https://ClinicalTrials.gov/show/NCT03092843 Recruiting The Cleveland Clinic 2020-05-30
NCT03076580 An Integrative-“Omics” Study of Cardiomyopathy Patients for Diagnosis and Prognosis in China https://ClinicalTrials.gov/show/NCT03076580 Recruiting Beijing Institute of Heart, Lung and Blood Vessel Diseases 2018-07-01
NCT03061994 Metabolomic Study of All-age Cardiomyopathy https://ClinicalTrials.gov/show/NCT03061994 Recruiting Beijing Institute of Heart, Lung and Blood Vessel Diseases 2019-10-31
NCT03043209 Genomic Sequencing in Patients With HCM Undergoing Septal Myectomy https://ClinicalTrials.gov/show/NCT03043209 Recruiting The Cleveland Clinic 2020-12-31
NCT03040947 MRI Sequence and Imaging Protocol Development https://ClinicalTrials.gov/show/NCT03040947 Recruiting National Heart Centre Singapore 2020-11-30
NCT02922517 Predictive Factors and Consequences of Myocardial Fibrosis in Hypertrophic Cardiomyopathy https://ClinicalTrials.gov/show/NCT02922517 Recruiting Nantes University Hospital 2017-12-31
NCT02806479 Hypertrophic Cardiomyopathy Pilot Study https://ClinicalTrials.gov/show/NCT02806479 Active, not recruiting Oregon Health and Science University 2020-06-30
NCT02804269 Molecular and Imaging Studies of Cardiovascular Health and Disease https://ClinicalTrials.gov/show/NCT02804269 Recruiting National Heart Centre Singapore 2033-07-31
NCT02696135 The Chinese Hypertrophic Cardiomyopathy Study(CHCS) https://ClinicalTrials.gov/show/NCT02696135 Recruiting China National Center for Cardiovascular Diseases 2025-12-31
NCT01559714 A Biomarker and MRI Study on Troponin Release After Exercise in Hypertrophic Cardiomyopathy https://ClinicalTrials.gov/show/NCT01559714 Completed Heartcenter, University Medical Center St. Radboud 2019-05-01
NCT00156429 Genetic Predictors of Outcome in HCM Patients https://ClinicalTrials.gov/show/NCT00156429 Active, not recruiting University of Pittsburgh 2021-05-31
NCT02432092 Pediatric Cardiomyopathy Mutation Analysis https://ClinicalTrials.gov/show/NCT02432092 Recruiting Indiana University 2019-04-30
NCT02417311 Individualized Early Risk Assessment for Heart Diseases https://ClinicalTrials.gov/show/NCT02417311 Active, not recruiting Universitätsklinikum Hamburg-Eppendorf 2019-06-30
NCT02234336 Assessment of Wall Thickness in Hypertrophic Cardiomyopathy https://ClinicalTrials.gov/show/NCT02234336 Completed Mayo Clinic 2017-07-25
NCT01873976 Cardiac Biomarkers in Pediatric Cardiomyopathy (PCM Biomarkers) https://ClinicalTrials.gov/show/NCT01873976 Active, not recruiting Wayne State University 2017-01-31
NCT01873963 Genotype-Phenotype Associations in Pediatric Cardiomyopathy (PCM GENES) https://ClinicalTrials.gov/show/NCT01873963 Completed Wayne State University 2017-02-28
NCT01623245 Prevalence of Transthyretin Amyloidosis in Hypertrophic Cardiomyopathy https://ClinicalTrials.gov/show/NCT01623245 Completed French Cardiology Society 2014-12-31
NCT04439942 4D-flow MRI to Assess Left Ventricular Obstruction in Hypertrophic Cardiomyopathy https://ClinicalTrials.gov/show/NCT04439942 Recruiting Centre Hospitalier Universitaire, Amiens 2022-06-30
NCT04402268 Efficacy of Risk Assessment for Sudden Cardiac Death in Patients With Hypertrophic Cardiomyopathy https://ClinicalTrials.gov/show/NCT04402268 Completed Poznan University of Medical Sciences 2018-09-01
NCT04112290 A Prospective Incident Study of Arrhythmias in Hypertrophic Cardiomyopathy https://ClinicalTrials.gov/show/NCT04112290 Recruiting Mayo Clinic 2023-11-05
NCT04080492 Inherited and Non-inherited Cardiac Disease Quality of Life https://ClinicalTrials.gov/show/NCT04080492 Recruiting The Cleveland Clinic 2023-06-30
NCT04056715 Extended ECG Monitoring in HCM Patients https://ClinicalTrials.gov/show/NCT04056715 Recruiting iRhythm Technologies, Inc. 2022-01-01
NCT04036799 PRecIsion Medicine in CardiomyopathY https://ClinicalTrials.gov/show/NCT04036799 Active, not recruiting The Hospital for Sick Children 2020-12-31
NCT03726424 Outcome of Different Pathogenic Mutations in Hypertrophic Cardiomyopathy https://ClinicalTrials.gov/show/NCT03726424 Recruiting Tongji Hospital 2019-12-31
NCT03572569 Risk Stratification in Children and Adolescents With Primary Cardiomyopathy https://ClinicalTrials.gov/show/NCT03572569 Recruiting German Heart Institute 2020-12-31
NCT01198899 Belgian Screening Project for the Detection of Anderson-Fabry Disease in Hypertrophic Cardiomyopathy https://ClinicalTrials.gov/show/NCT01198899 Completed University Hospital, Ghent 2011-08-31
NCT01160536 The Perceived Impact of Children s Risk Status for Hypertrophic Cardiomyopathy on Families: an Exploratory Study https://ClinicalTrials.gov/show/NCT01160536 Completed National Institutes of Health Clinical Center (CC) NA
NCT01091480 French Hypertrophic Cardiomyopathy Observatory https://ClinicalTrials.gov/show/NCT01091480 Recruiting French Cardiology Society 2023-12-31
NCT02994615 Evaluating Microvascular Dysfunction in Symptomatic Patients With HypertroPhic CaRdiomyopathy https://ClinicalTrials.gov/show/NCT02994615 Recruiting Lawson Health Research Institute 2020-06-30
NCT00753233 Identification of Risk Factors for Arrhythmia in Children and Adolescents With Hypertrophic Cardiomyopathy https://ClinicalTrials.gov/show/NCT00753233 Completed National Institutes of Health Clinical Center (CC) NA
NCT00692991 Using Magnetic Resonance Imaging to Evaluate Heart Vessel Function After Angioplasty or Stent Placement Procedures https://ClinicalTrials.gov/show/NCT00692991 Completed Johns Hopkins University 2016-01-31
NCT00589836 Assessment of Left Ventricular Torsion by Echocardiography Study https://ClinicalTrials.gov/show/NCT00589836 Completed The Cleveland Clinic 2008-04-30
NCT00354328 Heart Function and Exercise Capacity in Patients With Hypertrophic Cardiomyopathy https://ClinicalTrials.gov/show/NCT00354328 Completed National Institutes of Health Clinical Center (CC) NA
NCT00253682 Effects of Highly Active Anti-Retroviral Therapy on Cardiovascular Health in Infants of HIV-Infected Mothers https://ClinicalTrials.gov/show/NCT00253682 Completed University of Miami 2006-12-31
NCT00074880 The Role of Heart Stiff and Weak Atrium on Exercise Capacity in Patients With Hypertrophic Cardiomyopathy https://ClinicalTrials.gov/show/NCT00074880 Completed National Institutes of Health Clinical Center (CC) NA
NCT00001881 Signs and Symptoms of Genetic Abnormalities Linked to Inherited Heart Disease https://ClinicalTrials.gov/show/NCT00001881 Completed National Institutes of Health Clinical Center (CC) NA
NCT00001871 Study of Muscle Abnormalities in Patients With Specific Genetic Mutations https://ClinicalTrials.gov/show/NCT00001871 Completed National Institutes of Health Clinical Center (CC) NA
NCT00001530 Long-Term Results of DDD Pacing in Obstructive Hypertrophic Cardiomyopathy https://ClinicalTrials.gov/show/NCT00001530 Completed National Institutes of Health Clinical Center (CC) NA
NCT00001459 Analysis of Heart Muscle Function in Patients With Heart Disease and Normal Volunteers https://ClinicalTrials.gov/show/NCT00001459 Completed National Institutes of Health Clinical Center (CC) NA
NCT00005251 Genetic Analysis of Familial Hypertrophic Cardiomyopathy https://ClinicalTrials.gov/show/NCT00005251 Completed National Heart, Lung, and Blood Institute (NHLBI) NA
NCT00001878 Factors Contributing to Increased Left Ventricle Size in Patients With Abnormally Enlarged Hearts https://ClinicalTrials.gov/show/NCT00001878 Completed National Institutes of Health Clinical Center (CC) NA
NCT00001746 Screening for Inherited Heart Disease https://ClinicalTrials.gov/show/NCT00001746 Completed National Institutes of Health Clinical Center (CC) NA
NCT00001632 Investigation Into the Use of Ultrasound Technique in the Evaluation of Heart Disease https://ClinicalTrials.gov/show/NCT00001632 Completed National Institutes of Health Clinical Center (CC) NA
NCT00001534 Long Term Effects of Enalapril and Losartan on Genetic Heart Disease https://ClinicalTrials.gov/show/NCT00001534 Completed National Institutes of Health Clinical Center (CC) NA
NCT00001225 Family Studies of Inherited Heart Disease https://ClinicalTrials.gov/show/NCT00001225 Completed National Institutes of Health Clinical Center (CC) NA

Registries

#If less then 500 registries

nct_id brief_title link overall_status source primary_completion_date
NCT03049995 Stress Echo 2020 - The International Stress Echo Study https://ClinicalTrials.gov/show/NCT03049995 Recruiting Fatebenefratelli Hospital 2020-12-31
NCT02549664 Exercise in Genetic Cardiovascular Conditions https://ClinicalTrials.gov/show/NCT02549664 Active, not recruiting Yale University 2021-12-30
NCT02413450 Derivation of Human Induced Pluripotent Stem (iPS) Cells to Heritable Cardiac Arrhythmias https://ClinicalTrials.gov/show/NCT02413450 Enrolling by invitation Johns Hopkins University 2023-08-31
NCT01915615 HCMR - Novel Markers of Prognosis in Hypertrophic Cardiomyopathy https://ClinicalTrials.gov/show/NCT01915615 Active, not recruiting University of Virginia 2022-04-30
NCT01792960 Registry and Prevalence of Gene Mutation in Korean Patients With Familial Hypertrophic Cardiomyopathy https://ClinicalTrials.gov/show/NCT01792960 Completed Yonsei University 2013-08-31
NCT01334801 Biomarkers in Aortic Stenosis - B.A.S.S. https://ClinicalTrials.gov/show/NCT01334801 Recruiting Mayo Clinic 2025-12-31
NCT04189822 Hearts in Rhythm Organization (HiRO)National Registry and Bio Bank https://ClinicalTrials.gov/show/NCT04189822 Enrolling by invitation University of British Columbia 2025-12-31
NCT03527342 Sahlgrenska Cardiomyopathy Project https://ClinicalTrials.gov/show/NCT03527342 Enrolling by invitation Göteborg University 2028-01-31